Suicidality in schizophrenic patients with and without obsessive-compulsive disorder

2007 ◽  
Vol 90 (1-3) ◽  
pp. 198-202 ◽  
Author(s):  
L SEVINCOK ◽  
A AKOGLU ◽  
F KOKCU
1999 ◽  
Vol 9 ◽  
pp. 262-263 ◽  
Author(s):  
M. Poyurovsky ◽  
V. Kris ◽  
G. Weisman ◽  
S. Hromnikov ◽  
V. Isakov ◽  
...  

2004 ◽  
Vol 34 (3) ◽  
pp. 451-460 ◽  
Author(s):  
R. LENCER ◽  
P. TRILLENBERG ◽  
K. TRILLENBERG-KRECKER ◽  
K. JUNGHANNS ◽  
A. KORDON ◽  
...  

Background. In schizophrenia, affective disorders, and obsessive–compulsive disorder (OCD) dysfunction of frontal neuronal circuits has been suggested. Such impairments imply corresponding oculomotor deficits.Method. Eye movement response to foveofugal and foveopetal step–ramp stimuli was recorded within the same study design in patients with schizophrenia (N=16), affective disorder (N=15), and OCD (N=18) and compared with controls (N=23) using infra-red reflection oculography.Results. In the foveofugal task steady-state velocity was lower in all patient groups compared with controls. Post-saccadic eye velocity was also decreased in patients with schizophrenia and affective disorder. In the foveopetal stimulus steady-state velocity was reduced in schizophrenic patients, only. Changes of saccadic latencies or position errors were not found in any of the patient groups. Also, pursuit latency was unchanged and initial eye acceleration was not decreased.Conclusions. Unaltered saccadic parameters indicate intact motion perception in cortical visual area V5. Therefore, the observed deficit of pursuit maintenance implies a dysfunction of frontal networks in all patient groups including the pursuit region of the frontal eye field (FEF). In patients with schizophrenia and affective disorder reduced post-saccadic pursuit initiation may indicate an impaired interaction between the pursuit and the saccadic system.


CNS Spectrums ◽  
2013 ◽  
Vol 19 (4) ◽  
pp. 340-346 ◽  
Author(s):  
Giacomo Grassi ◽  
Lorenzo Poli ◽  
Andrea Cantisani ◽  
Lorenzo Righi ◽  
Gabriella Ferrari ◽  
...  

ObjectiveThe aim of the study was to investigate the prevalence rates of obsessive-compulsive disorder (OCD) and hypochondriasis in schizophrenic patients treated with atypical antipsychotics (AAPs) and to investigate the different comorbidity rates of OCD and hypochondriasis between clozapine-treated patients and patients treated with other AAPs.MethodsWe therefore recruited 60 schizophrenic patients treated with clozapine or other AAPs. We assessed the prevalence rates of OCD or OC symptoms and hypochondriasis or hypochondriac symptoms in the whole group of patients and in clozapine-treated patients versus patients treated with other AAPs.ResultsSchizophrenic patients had a higher comorbidity rate of OCD (26.6% vs 1–3%) and hypochondriasis (20% vs 1%) than the general population. These comorbidities were more frequent in schizophrenic patients treated with clozapine versus patients treated with other AAPs (36.7% vs 16.7% and 33.3% vs 6.7%). Clozapine-treated patients showed a higher mean Y-BOCS and HY-BOCS score when compared to patients treated with other AAPs (10.90 vs 5.90, p = .099; 15.40 vs 8.93, p = .166). A statistical significant correlation was found between the Y-BOCS and HY-BOCS scores of the whole group (r = .378, p = 0.03). Furthermore, we found an inverse correlation between the global level of functioning and the diagnosis of hypochondriasis (p = .048) and the severity of hypochondriac symptoms (p = .047).ConclusionsHypochondriasis could represent an important clinical feature of schizophrenic patients treated with atypical antipsychotics, and further research is needed in this field.


Sign in / Sign up

Export Citation Format

Share Document